Please login to the form below
data access
This page shows the latest data access news and features for those working in and with pharma, biotech and healthcare.
US regulators set to approve oral antiviral against COVID-19
That is why we are moving with speed and rigor to pursue authorisations and to accelerate broad global access to this investigational medicine.”. ... The data behind molnupiravir is from the phase 3 MOVe-OUT clinical trial in non-hospitalised adult
Latest news
-
UK’s NICE recommends Roche’s Evrysdi
deal. The National Institute for Health and Care Excellence (NICE) has recommended that Roche’s Evrysdi (risdiplam) be made available to patients in England as part of a managed access agreement. ... The deal agreed by Roche and NHS England will see 1,
-
J&J, distributors reach $26bn settlement to address the opioid crisis in the US
The pharma giant will also have to share clinical trial data under the Yale Open Data Access Project.
-
Health leaders welcome EDPB’s opinion on adequacy of UK’s data protection standards
Opinion ‘paves way’ for sharing of health data between EU and the UK. ... We hope the draft data adequacy decision will be approved, and that the NHS and European health care systems can continue to benefit from having access to each other’s health
-
Italy accelerates the path towards digital therapeutics implementation
new therapeutic treatments that will mark the future of medicine, with a crucial impact on patients in terms of access to treatment and the sustainability of healthcare systems. ... that would allow the various aspects of research, access and
-
Red Havas Health launch unites health professionals from across the globe
By uniting our fantastic talent from key markets, our new full-service global PR offering will provide clients even greater access to the best thinking, technology, data and insights,” he added.
More from news
Approximately 1 fully matching, plus 208 partially matching documents found.
Latest Intelligence
-
Public is more comfortable with health data sharing if they know it is to support breakthrough treatments and vaccines
By Andrew Harrison. Timely access to anonymised health data has been central to UK and global pandemic responses. ... The pandemic has shown there are major benefits to be seized through better data sharing.
-
Staying in the loop – six principles for impactful integrated communications
5. Analyse and ask why: as well as having clear objectives behind movements, there needs to be access to data, a curiosity to ask why, and applied expertise to identify whether
-
The pursuit of patient diversity in clinical trials
treatments. The process generates qualitative data on the engagement and experiences of patients and can be used to inform protocol design.”. ... If you can set up your trials so that you can access electronic medical records and review data remotely,
-
Transforming clinical trial data into a long-term asset
Meanwhile, 65% of compliance, legal and regulatory professionals described their ability to access archived trial data as ‘extremely inadequate’ or ‘very inadequate’. ... When it comes to the archive, patchy access to TMF data could hinder
-
2021: the year of decentralisation in drug development
As a result, these technologies have the potential to improve data quality, leading to better outcomes. ... With enhanced trial access across all demographics, study data will be more comprehensive for greater insight into developing new treatments.
More from intelligence
Approximately 0 fully matching, plus 72 partially matching documents found.
Latest appointments
-
Medmeme appoints Dr Joseph Laudano to medical affairs role
He said: “The medical affairs function is in the process of evolving from a traditional support role into a more robust, strategic organisation for data generation and dissemination. ... Mahesh Naithani, founder of Medmeme, said: “Medmeme has been
-
Natasha Giordano joins PLx Pharma
I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic
With better access to health data, HCPs can monitor patients from afar – reducing pressure on the system and leading to more timely detection if someone’s condition is deteriorating. ... Effective flow of data from RPM to patient records also has
-
We must be candid about our use of healthcare data if we want to win back public trust
So where do we go from here, and how should those of us who recognise the importance of good access to NHS data make our voices heard? ... Without good access to data, we would be unable to monitor the long-term impact of different models of care; we
-
Staying in the loop – six principles for impactful integrated communications
Analyse and ask why: as well as having clear objectives behind movements, there needs to be access to data and curiosity to ask why.
-
Pharmerit rebrands to OPEN Health
centered outcomes expertise, the inclusion of primary data collection capabilities, and extensive access to UK and European databases. ... This will allow us to combine our novel data analytics and machine learning expertise with deep commercial market
-
How a design mindset can lead to better medical outcomes
This means presenting information in a form that patients can easily access and understand, will become more prevalent. ... Digital – in all its guises – from access to electronic data and real-time information to AI, has allowed clinicians’ work
Stick or twist? Looking at the patient experience as we emerge from the COVID pandemic
More from PMHub
Approximately 0 fully matching, plus 52 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Scientific Director, MRNA/ Covid 19, Medical Communications, UK
-
Six figure salary
-
B2B media account director
-
Competitive salary
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Principal Medical Writer, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- Account Supervisor – Leading Healthcare Advertising Agency – New...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Exec > CSD – Medical Communications – UK, Lond...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers > Scientific Directors – Medical Communicatio...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer – Creative Healthcare Advertising – New Yo...
-
Highly Competitive Salary, Bonus &Benefits
- Vaccines writer – career opportunity to move into medcomms from ...
-
Highly competitive salary
- First trial of a vaccine against Alzheimer’s launches
- US government to pay $5.3bn for Pfizer‘s Paxlovid
- Roche to present new data for its drug Polivy at the American Society of Hematology’s annual meeting
- Novo Nordisk growth takes a hit with China deal
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Merck enters agreement with Hanmi for investigational NASH drug
- Booster plans expanded to combat Omicron
- US regulators set to approve oral antiviral against COVID-19
- What does the future hold for Light-chain Amyloidosis?
- As HCPs Increasingly Expect Personalized Engagement, Pharmas Turn to Modular Intelligent Content. How Does This Work?
- COVID-19 vaccines against Omicron may be fast-tracked
- BMS’ new JAK inhibitor enters regulatory pathways
- Results for Merck’s oral cholesterol inhibitor show it to be ‘highly effective’
- Biogen hands out $120m upfront for Remedy stroke drug
- Pfizer's 2021 revenue predictions soar to $82bn
- Gilead’s Trodelvy approved for triple-negative breast cancer in Europe
- Pfizer fined $60m for bribing doctors to win business
- Synairgen’s SNG001 advances into phase 3 COVID-19 trial
PMHub
foxandcat.online
some pressure is helpful but too much of the wrong sort quickly takes its toll. we help creatove agenices manage...
Latest intelligence
- What does the future hold for Light-chain Amyloidosis?
- Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
- Webinar:
- Securing a future for telehealth with immersive market research insights...
- Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
- How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
